NBTXR3 activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients

被引：0
|
作者：
Le Tourneau, C. [1 ]
Calugaru, V. [2 ]
Takacsi-Nagy, Z. [3 ]
Liem, X. [4 ]
Papai, Z. [5 ]
Moreno, V. [6 ]
Brana, I. [7 ]
Salas, S. [8 ]
Poissonnet, G. [9 ]
Calvo, E. [10 ]
Doger, B. [11 ]
Choussy, O. [12 ]
Mirabel, X. [13 ]
Krhili, S. [14 ]
Bernois, K. [15 ]
Fakhry, N. [16 ]
Kam, S. Wong Hee [17 ]
Borcoman, E. [18 ]
Hoffmann, C.
机构：
[1] Inst Curie Drug Dev & Innovat D3i, Paris, France
[2] Inst Curie Radiat Therapy, Paris, France
[3] Natl Inst Oncol, Ctr Radiotherapy, Budapest, Hungary
[4] Oscar Lambret Canc Ctr, Radiotherapy Brachytherapy, Lille, France
[5] Med Ctr, Hungarian Def Forces, Oncol, Budapest, Hungary
[6] START Fdn Jimenez Diaz, Phase I Clin Trials Unit, Madrid, Spain
[7] Hebron Inst Oncol, Early Clin Drug Dev Grp, Barcelona, Spain
[8] Hop La Timone, Med Oncol Palliat Care Serv, Marseille, France
[9] Unicanc Antoine Lacassagne Ctr, Cerv Facial Oncol Surg, Nice, France
[10] START Hosp Sanchinarro, Med Oncol Serv, Madrid, Spain
[11] START Fdn Jimenez Diaz, Med Oncol Serv, Madrid, Spain
[12] Inst Curie, Dept Surg Oncol, Paris, France
[13] Oscar Lambret Canc Ctr, Dept Radiotherapy Brachytherapy, Lille, France
[14] Inst Curie, Dept Radiat Therapy, Paris, France
[15] Nanobiotix, Biomet, Paris, France
[16] Hop La Timone, ENT & Cervico Facial Surg Serv, Marseille, France
[17] Hop La Timone, Radiat Oncol, Marseille, France
[18] Inst Curie, Drug Dev & Innovat D3i, Paris, France
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 161卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0515
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [1] Phase I Study of Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients
    Le Tourneau, C.
    Calugaru, V.
    Takacsi-Nagy, Z.
    Liem, X.
    Papai, Z.
    Fijuth, J.
    Garcia, V. Moreno
    Garcia, I. Brana
    Salas, S.
    Poissonnet, G.
    Calvo, E.
    Doger, B.
    Choussy, O.
    Mirabel, X.
    Krhili, S.
    Bernois, K.
    Fakhry, N.
    Kam, S. Wong Hee
    Borcoman, E.
    Hoffmann, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E392 - E392
  • [2] Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final Results of a Phase I Trial
    Le Tourneau, C.
    Takacsi-Nagy, Z.
    Finzi, L.
    Liem, X.
    Calugaru, V.
    Moreno, V.
    Calvo, E.
    Salas, S.
    Doger, B.
    Dubray-Vautrin, A.
    Mirabel, X.
    Badois, N.
    Chilles, A.
    Fakhry, N.
    Kam, S. Wong Hee
    Houdas, L.
    Debard, A.
    Vivar, O. I.
    Farber, L. A.
    Lesnik, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S99 - S99
  • [3] Phase I study of functionalized hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.
    Le Tourneau, Christophe
    Calugaru, Valentin
    Takacsi-Nagy, Zoltan
    Liem, Xavier
    Papai, Zsuzsanna
    Fijuth, Jacek
    Moreno, Victor
    Giralt, Jordi
    Salas, Sebastien
    Poissonnet, Gilles
    Calvo, Emiliano
    Doger, Bernard
    Choussy, Olivier
    Mirabel, Xavier
    Krhili, Samar
    Bernois, Katell
    Fakhry, Nicolas
    Wong-Hee-Kam, Stephanie
    Borcoman, Edith
    Hoffmann, Caroline
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final and Exploratory Results of a Phase I Trial
    Le Tourneau, C.
    Liem, X.
    Nguyen, T. V. F.
    El Bedoui, S.
    Salas, S.
    Serrahima, M. Plana
    Mirabel, X.
    Kam, S. Wong Hee
    Houdas, L.
    Debard, A.
    Vivar, O. I.
    Farber, L. A.
    Thariat, J. O.
    Lesnik, M.
    Helferich, F.
    Herczeg, A.
    Papai, Z.
    Fijuth, J.
    Takacsi-Nagy, Z.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E6 - E6
  • [5] NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Activated By Radiotherapy In Cisplatin-Ineligible Patients With Locally Advanced HNSCC: A Phase I Trial
    Le Tourneau, C.
    Calugaru, V.
    Borcoman, E.
    Moreno, V.
    Calvo, E.
    Liem, X.
    Salas, S.
    Doger, B.
    Choussy, O.
    Lesnik, M.
    Mirabel, X.
    Badois, N.
    Krhili, S.
    Blomkvist, J.
    Fakhry, N.
    Kam, S. Wong Hee
    Hoffmann, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E792 - E792
  • [6] Radiation enhancing hafnium oxide nanoparticles (NBTXR3) for the treatment of cisplatin-ineligible locally advanced HNSCC patients: a phase I dose expansion study
    Le Tourneau, Christophe
    Calugaru, Valentin
    Moreno, Victor
    Calvo, Emiliano
    Liem, Xavier
    Salas, Sebastien
    Doger, Bernard
    Jouffroy, Thomas
    Mirabel, Xavier
    Rodriguez, Jose
    Chilles, Anne
    Bernois, Katell
    Fakhry, Nicolas
    Kam, Stephanie Wong Hee
    Hoffmann, Caroline
    [J]. ORAL ONCOLOGY, 2021, 118
  • [7] Antitumor activity of the radioenhancer NBTXR3 on injected lesions to estimate overall survival: Exploratory analyses from a phase I in cisplatin-ineligible locally advanced HNSCC patients
    Le Tourneau, C.
    Takacsi-Nagy, Z.
    Liem, X.
    Calugaru, V.
    Moreno Garcia, V.
    Calvo, E.
    Salas, S.
    Doger De Speville, B.
    Dubray-Vautrin, A.
    Mirabel, X.
    Badois, N.
    Chilles, A.
    Fakhry, N.
    Hee Kam, S. Wong
    Debard, A.
    Serra, A.
    Finzi, L.
    Vivar, O. I.
    Farber, L. A.
    Lesnik, M.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S568 - S569
  • [8] RT-activated hafnium oxide nanoparticles in cisplatin-ineligible locally advanced HNSCC patients
    Le Tourneau, C.
    Calugaru, V.
    Borcoman, E.
    Moreno, V.
    Calvo, E.
    Liem, X.
    Salas, S.
    Doger, B.
    Jouffroy, T.
    Mirabel, X.
    Rodriguez, J.
    Chilles, A.
    Bernois, K.
    De Rink, M.
    Fafhry, N.
    Kam, S. Wong Hee
    Hoffmann, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S312 - S312
  • [9] Phase I trial of hafnium oxide nanoparticles activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.
    Le Tourneau, Christophe
    Calugaru, Valentin
    Borcoman, Edith
    Moreno, Victor
    Calvo, Emiliano
    Liem, Xavier
    Salas, Sebastien
    Doger, Bernard
    Choussy, Olivier
    Lesnik, Maria
    Mirabel, Xavier
    Badois, Nathalie
    Krhili, Samar
    Blomkvist, Josefin
    Fakhry, Nicolas
    Wong-Hee-Kam, Stephanie
    Hoffmann, Caroline
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] NBTXR3 for the Treatment of Elderly Frail Patients with Locally Advanced HNSCC
    Le Tourneau, C.
    Calugaru, V.
    Moreno Garcia, V.
    Mirabel, X.
    Doger, B.
    Calvo, E.
    Fijuth, J.
    Rutkowski, T.
    Magne, N.
    Sanz Taberna, M.
    Contreras, J.
    Brana Garcia, I.
    Papai, Z.
    Takacsi-Nagy, Z.
    Liem, X.
    Salas, S.
    Kam, S. Wong Hee
    Florescu, C.
    Thariat, J. O.
    Hoffmann, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S54 - S55
12345